Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04929028
Title Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

anal squamous cell carcinoma

rectum squamous cell carcinoma

Therapies

Capecitabine + Mitomycin C

Nivolumab

Fluorouracil + Mitomycin C

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.